Work

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Year: 2020

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.04.694

Authors: Bhavana Pothuri, Angeles Alvarez Secord, Deborah K. Armstrong, John Chan, Amanda N. Fader, Warner Huh, Joshua Kesterson, Joyce F. Liu, Kathleen Moore, Shannon N. Westin, R. Wendel Naumann

Institutions: NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Duke University Health System, Duke Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, University of Alabama at Birmingham, Penn State Milton S. Hershey Medical Center, Dana-Farber Cancer Institute, OU Health Stephenson Cancer Center, The University of Texas MD Anderson Cancer Center, Levine Cancer Institute

Language: English

Topic: COVID-19 and healthcare impacts

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3020169154

FWCI: 3.449

Cites: 86

Cited by: 54

Related to: 10